Lawmaker Wants Details On Rule For Drug Marketing

Law360, New York (January 23, 2008, 12:00 AM EST) -- A Democratic lawmaker has once again demanded that the Food and Drug Administration turn over information about a draft proposal that would give drug companies free rein to use journal articles to promote unapproved medication uses.

Rep. Henry Waxman, chair of the House Committee on Oversight and Government Reform, sent the FDA a second letter on Tuesday, after the agency responded to his first request for information with a single document. The information the lawmaker demanded contained “predecisional information” that reflected ongoing deliberations, the FDA said...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.